| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b015ca2b2715b74db5868852efe71c9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a36c66685971b78daf233b5999ead4c2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2020-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6e2d920baa8a04764ec749fffbfbcef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e445e884c5582dc19a3ed45c47b9fd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_329d947fe67734e19ebccdfa53025ef3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4c7af8942ee21b3ed61cab61319dd08 |
| publicationDate |
2021-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021057764-A1 |
| titleOfInvention |
Use of pd-1 antibody in combination with taxoid compound in preparation of drugs for treating triple-negative breast cancer |
| abstract |
Provided is use of a PD-1 antibody in combination with a molecular chemotherapeutic agent, such as paclitaxel in preparation of drugs for treating triple-negative breast cancer. The combination treatment scheme has a synergistic effect. |
| priorityDate |
2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |